Transcriptomic and metabolomic preclinical studies show that polyphenolic extracts may regulate genes and pathways linked to MASLD, suppressing pro-inflammatory pathways while activating the anti-inflammatory PPAR pathway, suggesting their therapeutic potential in MASLD treatment [139]. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatotic liver disease.